PRKCQ

PRKCQ Full Name

protein kinase C, theta

PRKCQ Introduction

Protein kinase C theta (PRKCQ, or PKCθ) is a structurally and functionally distinct member of the "novel" protein kinase C (nPKC) subfamily. Consistent with other nPKCs, its enzymatic activation is dependent on diacylglycerol (DAG) and membrane phospholipids, but it functions entirely independent of calcium ions. What sets PRKCQ apart from its ubiquitous family members is its highly restricted tissue distribution: it is predominantly and robustly expressed in hematopoietic cells—most crucially in T lymphocytes (T cells)—and is also found in skeletal muscle.

Figure 1. PKC-θ translocation in immune synapse. (Source: Brezar V, et al. 2015)

PRKCQ is an absolute requisite for mature T cell activation, survival, and differentiation. Upon simultaneous engagement of the T cell receptor (TCR) and the CD28 costimulatory molecule, PRKCQ rapidly translocates to the center of the immunological synapse. In this unique subcellular compartment, it physically couples proximal receptor signaling to distal transcription factors. Specifically, PRKCQ is the indispensable kinase responsible for linking TCR signals to the activation of the IKK/NF-κB complex, as well as the AP-1 and NFAT pathways. This molecular cascade ultimately drives the robust production of interleukin-2 (IL-2) and fuels T cell proliferation. Because of its central, non-redundant role in driving T cell effector functions, the dysregulation of PRKCQ is fundamentally linked to a wide array of T cell-mediated autoimmune and inflammatory pathologies. Aberrant or sustained PRKCQ signaling heavily promotes the pathogenesis of severe conditions such as rheumatoid arthritis, multiple sclerosis, and allergic asthma.

Because PRKCQ is essential for autoimmune responses but largely dispensable for baseline antiviral immunity, it is currently recognized as a premier, high-value target for developing novel, selective immunosuppressive drugs that avoid the broad toxicities of traditional therapies. Beyond immunology, PRKCQ plays a critical pathological role in metabolism. In skeletal muscle, the abnormal accumulation of intracellular lipids (such as in obesity) leads to the chronic overactivation of PRKCQ. This overactivation directly phosphorylates and inhibits insulin receptor substrate-1 (IRS-1), serving as a primary molecular mechanism driving lipid-induced insulin resistance and the progression of type 2 diabetes.

Alternate Names for PRKCQ

PRKCQ; protein kinase C, theta; PRKCT; nPKC-theta; protein kinase C theta type;

• 1. Brezar V, et al. PKC-Theta in Regulatory and Effector T-cell Functions. Front Immunol. 2015 Oct 13;6:530.
  2. Hayashi K, et al. Protein kinase C theta (PKCtheta): a key player in T cell life and death. Pharmacol Res. 2007 Jun;55(6):537-44.